0 Комментарии
0 Поделились
144 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Статьи пользователей
-
Marketplace
-
Форумы
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Advanced Renal Cell Carcinoma Therapeutics Market: 7.3% CAGR Growth Through 2030According to a newly published market research report by 24LifeSciences, global advanced renal cell carcinoma therapeutics market was valued at USD 3.2 billion in 2023 and is projected to reach USD 5.8 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 20242030. Advanced renal cell carcinoma therapeutics encompass targeted therapies,...0 Комментарии 0 Поделились 331 Просмотры 0 предпросмотр
-
Advanced Renal Cell Carcinoma Therapeutics Market: 7.3% CAGR Growth Through 2030According to a newly published market research report by 24LifeSciences, global advanced renal cell carcinoma therapeutics market was valued at USD 3.2 billion in 2023 and is projected to reach USD 5.8 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 20242030. Advanced renal cell carcinoma therapeutics encompass targeted therapies,...0 Комментарии 0 Поделились 317 Просмотры 0 предпросмотр
-
Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis"In-Depth Study on Executive Summary Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size and Share The Asia-Pacific natural killer (NK) cell therapeutics market is supportive and aims to reduce the progression of the disease. Data Bridge Market Research analyzes that Asia-Pacific natural killer (NK) cell therapeutics market will grow at a CAGR of 45.2% during the forecast...0 Комментарии 0 Поделились 521 Просмотры 0 предпросмотр
-
Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis"In-Depth Study on Executive Summary Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size and Share The Asia-Pacific natural killer (NK) cell therapeutics market is supportive and aims to reduce the progression of the disease. Data Bridge Market Research analyzes that Asia-Pacific natural killer (NK) cell therapeutics market will grow at a CAGR of 45.2% during the forecast...0 Комментарии 0 Поделились 565 Просмотры 0 предпросмотр
-
Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size, Share, Trends, Key Drivers, Growth and Opportunity Analysis"Executive Summary Asia-Pacific Natural Killer (NK) Cell Therapeutics Market: Growth Trends and Share Breakdown The Asia-Pacific natural killer (NK) cell therapeutics market is supportive and aims to reduce the progression of the disease. Data Bridge Market Research analyzes that Asia-Pacific natural killer (NK) cell therapeutics market will grow at a CAGR of 45.2% during the forecast...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Basal Cell Carcinoma Therapeutics Market to Reach USD 14.6 Billion by 2032 | CAGR 7.3%According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032. Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Biotech Breakthroughs Accelerate the Global RNA Therapeutics MarketKey Drivers Impacting Executive Summary RNA Therapeutics Market Size and Share CAGR Value This global RNA Therapeutics Market research report carries out the methodical and comprehensive market research study that puts forth the facts and figures linked with any subject about RNA Therapeutics Market The forecast, analysis, evaluations, and estimations carried out in this RNA...0 Комментарии 0 Поделились 174 Просмотры 0 предпросмотр
-
Bispecific T Cell Engager Therapeutics Market to Grow at 15.8% CAGR (2025–2032)According to a newly published market research report by 24LifeSciences, global bispecific T cell engager therapeutics market was valued at USD 5.8 billion in 2024 and is projected to reach USD 20.1 billion by 2032, growing at a compound annual growth rate (CAGR) of 15.8% during the forecast period 20252032. Bispecific T cell engagers (BiTEs) represent a revolutionary class of...0 Комментарии 0 Поделились 325 Просмотры 0 предпросмотр
-
Bispecific T Cell Engager Therapeutics Market to Grow at 15.8% CAGR (2025–2032)According to a newly published market research report by 24LifeSciences, global bispecific T cell engager therapeutics market was valued at USD 5.8 billion in 2024 and is projected to reach USD 20.1 billion by 2032, growing at a compound annual growth rate (CAGR) of 15.8% during the forecast period 20252032. Bispecific T cell engagers (BiTEs) represent a revolutionary class of...0 Комментарии 0 Поделились 314 Просмотры 0 предпросмотр
-
Bone Metastasis Therapeutics Market Growth & CAGR 8.3% ForecastAccording to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Breakthrough Neuroscience Research Expands AMPA Receptor Therapeutics MarketExecutive Summary α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) Receptor Market Size and Share: Global Industry Snapshot The global α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor market size was valued at USD 274.69 million in 2024 and is expected to reach USD 431.25 million by 2032, at a CAGR of...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Antibody Drug Conjugates Market Expansion with New Cancer TherapiesNorth America currently holds a significant share in the antibody drug conjugates market due to strong research infrastructure and high healthcare spending. The presence of major pharmaceutical companies also supports regional growth. The Antibody Drug Conjugates (ADC) market is projected to grow significantly, reaching US$38,077.45 million by 2031 from US$8,105.65 million in 2023, registering...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Biologics and Biosimilars Market by 2031 – Segmentation Analysis, Trends, and Key PlayersThe biologics and biosimilars market is poised for significant growth over the next decade, driven by rising demand for advanced therapies to treat chronic, autoimmune, and life-threatening diseases. Biologics, complex medicines derived from living organisms, are increasingly preferred for their targeted therapeutic effects, while biosimilars offer highly similar alternatives at reduced costs,...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Biosimilars Market Opportunities for Pharma and Biotech CompaniesThe increasing role of biosimilars in hospital treatment protocols is another factor driving market growth. Hospitals are adopting biosimilars to manage healthcare budgets effectively. This shift is improving patient access to essential biologic therapies. The global Biosimilars Market is experiencing remarkable growth as healthcare systems increasingly adopt cost-effective alternatives...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Can Emerging Therapies Improve Outcomes in PFIC Type 2 Treatment?Progressive Familial Intrahepatic Cholestasis Type 2 Treatment Market Summary: According to the latest report published by Data Bridge Market Research, the Progressive Familial Intrahepatic Cholestasis Type 2 Treatment Market CAGR Value Progressive Familial Intrahepatic Cholestasis Type 2 Treatment Market is the finest market research report which is the result of...0 Комментарии 0 Поделились 634 Просмотры 0 предпросмотр
-
Can RNA-Based Therapeutics Revolutionize Cancer Treatment?RNA-Based Cancer Therapeutics Market Summary: According to the latest report published by Data Bridge Market Research, the RNA-Based Cancer Therapeutics Market CAGR Value For structuring the finest market research report like this RNA-Based Cancer Therapeutics Market, a devoted team of experienced forecasters, well-versed analysts and knowledgeable researchers work...0 Комментарии 0 Поделились 467 Просмотры 0 предпросмотр
-
Can the Global Oral Antidiabetic Drugs Market Transform Diabetes Management Worldwide?Oral Antidiabetic Drugs Market Summary: According to the latest report published by Data Bridge Market Research, the Oral Antidiabetic Drugs Market CAGR Value This Oral Antidiabetic Drugs Market research report is prepared with detailed statistics and market research insights that results in sharp growth and thriving sustainability in the market for the businesses. This...0 Комментарии 0 Поделились 766 Просмотры 0 предпросмотр
-
Comprehensive Market Overview and Strategic Analysis of the Drugs of Bioengineered Protein Market 2034The Drugs of Bioengineered Protein Market report presents a detailed evaluation of the global landscape of bioengineered protein therapeutics, focusing on industry trends, segmentation, and growth trajectories that are reshaping modern healthcare. This expansive market includes a diverse range of biologic drugs such as cytokines and chemokines, peptide hormones, peptide antibiotics, monoclonal...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
Расширенные страницы
Спонсоры
Спонсоры
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek